Anixa Biosciences's total assets for Q were $24.36M, a decrease of -4.01% from the previous quarter. ANIX total liabilities were $1.77M for the fiscal quarter, a 0.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.